Tomei, L. (2023). Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Italian Journal of Pediatric Allergy and Immunology, 36(4), 40–41. Retrieved from https://www.riaponline.it/article/view/106